Lego köper vindkraft för miljarder - Aktuell Hållbarhet
Industrifonden ledde finansieringsrunda i greentechbolag
I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Read full article February 10, 2021, 10:00 PM · 4 EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry.
Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011. Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.
All about DR - Zip.news
The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.
Pressmeddelande: Investment AB Spiltan investerar 8 Mkr i
The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme is a biotechnology company that specializes in biocatalysis. EnginZyme erweitert Serie-A-Finanzierung auf 11 Mio. Euro, um seine zellfreie Chemieproduktionsplattform voranzubringen – Finanzierungsrunde geführt vom schwedischen Investor Industrifonden EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures. År på 33-listan: 2020.
EnginZyme seeks to transform the $5 trillion
Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture
The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. Enginzyme tar nu in 11 miljoner euro från SEB Greentech och Industrifonden samt existerande ägare. Det framgår av ett pressmeddelande. – Bolaget är i slutfasen av att bekräfta sin teknologi med fyra olika produkter så vi kommer in i en spännande fas, säger Markus Hökfelt, chef för SEB Greentech, i …
STOCKHOLM--(BUSINESS WIRE)-- EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders.
Ub umeå universitet öppettider
EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. The founding team behind EnginZyme – Karim Engelmark Cassimjee, Robin Chatterjee and Samuel Härgestam – is driven by the vision of a chemical industry free from the dependency with petrochemicals, toxic syntheses and polluting processes. 2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. Industrifonden is an early stage venture capital fund.
Industrifonden is a foundation established by the Swedish state in 1979 as a venture capital investor in early-stage growth companies in technology and life science sectors. The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden
EnginZyme is a biotechnology company that specializes in biocatalysis. EnginZyme erweitert Serie-A-Finanzierung auf 11 Mio. Euro, um seine zellfreie Chemieproduktionsplattform voranzubringen – Finanzierungsrunde geführt vom schwedischen Investor Industrifonden
EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as
The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--(
Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures.
Die nummer pl
EnginZyme is a biotechnology company that specializes in biocatalysis. Search Crunchbase. Advanced Search. Try Pro free Solutions. Products.
EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier. Det framgår av ett pressmeddelande.
Svenska flygplatser fsx
karlslundsskolan södra
tyskland skatteverket
utdelningsutrymme holdingbolag
peter sjöblom sixt
köra snöskoter regler
Assignments Mannheimer Swartling
– EnginZyme is developing a technology platform for sustainable production of chemicals. – The company has produced catalysts at multi-kilogram scales EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes. But the really big market is in the $6tn chemicals industry as well as for plastics and alternatives of petrochemicals. EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M)..
Webcutter wikipedia
utbildning informationssakerhet
Hållbarhet Realtid.se - Kapitalmarknad, finansiering
Latest round brings company's total series-A funding to €11m. Early-stage; 12 February 2021.